Skip to main content
. 2017 May 20;8(33):54722–54734. doi: 10.18632/oncotarget.18039

Table 1. Clinicopathological characteristics and correlation with PD-L1 and PD-1 expression.

Characteristic All cases Tumoral PDL1 Stromal PDL1 Stromal PD1
Negative Positive Negative Positive Negative Positive
Cases (%) Cases (%) Cases (%) p Cases (%) Cases (%) p Cases (%) Cases (%) p
Overall 27 (100) 22 (81) 5 (19) 11 (41) 16 (59) 10 (37) 17 (63)
Sex
Male 12 (44) 10 (45) 2 (40) 1.00* 4 (36) 8 (50) 0.70* 4 (40) 8 (47) 1.00*
Female 15 (56) 12 (55) 3 (60) 7 (64) 8 (50) 6 (60) 9 (53)
Age at diagnosis
Age ≤60 year 13 (48) 12 (55) 1 (20) 0.33* 8 (73) 5 (31) 0.03** 5 (50) 8 (47) 1.00*
Age >60 year 14 (52) 10 (45) 4 (80) 3 (27) 11 (69) 5 (50) 9 (53)
Tumor size, thickness N=23 N=20 N=3 N=10 N=13 N=9 N=14
Median [range], mm 1.0 [0.1-16.0] 0.9 [0.2-5.0] 6.0 [0.1-16.0] 0.40& 0.8 [0.2-5.0] 1.4 [0.1-16.0] 0.65& 0.6 [0.2-5.0] 1.2 [0.1-16.0] 0.56&
Tumor size, LBD N=24 N=19 N=5 N=10 N=14 N=9 N=15
Median [range], mm 9.5 [2.0-30.0] 10.0 [2.0-30.0] 6.0 [5.0-20.0] 0.89& 9.5 [2.0-12.0] 10.0 [2.0-30.0] 0.44& 7.0 [2.0-15.0] 10.0 [2.0-30.0] 0.48&
Location
Epibulbar 20 (74) 17 (77) 3 (60) 0.58* 9 (82) 11 (69) 0.66* 10 (100) 10 (59) 0.03*
Non-epibulbar 7 (26) 5 (23) 2 (40) 2 (18) 5 (31) 0 (0) 7 (41)
cTNM**
T1 20 (74) 17 (77) 3 (60) 0.58* 10 (82) 11 (69) 0.66* 10 (100) 10 (59) 0.03*
T2 7 (26) 5 (23) 2 (40) 2 (18) 5 (31) 0 (0) 7 (41)
Local recurrence
No 16 (59) 13 (59) 3 (60) 1.00* 6 (55) 10 (63) 0.71* 8 (80) 8 (47) 0.12*
Yes 11 (41) 9 (41) 2 (40) 5 (45) 6 (38) 2 (20) 9 (53)
Distant metastasis
No 23 (85) 21 (95) 2 (40) 0.01* 11 (100) 12 (75) 0.12* 10 (100) 13 (76) 0.27*
Yes 4 (15) 1 (5) 3 (60) 0 (0) 4 (25) 0 (0) 4 (24)

LBD = largest basal diameter. cTNM = clinical TNM stage, based on the first occurring conjunctival melanoma. P value calculation: * = Fischer exact test; ** = Pearson's chi-square; & = Mann Whitney U test. Italic P values are ≤ 0.05.